ABBOTT LABORATORIES·4

Jan 5, 6:26 PM ET

Roman Michael F 4

4 · ABBOTT LABORATORIES · Filed Jan 5, 2026

Insider Transaction Report

Form 4
Period: 2025-12-31
Transactions
  • Award

    Stock Equivalent Units

    2025-12-31$125.29/sh+301$37,7125,882 total
    Common Shares (301 underlying)
Footnotes (2)
  • [F1]Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
  • [F2]Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Documents

1 file
  • 4
    form4-01052026_110105.xmlPrimary